NMRA Medical Device Registration & Local Agent (MAH) Sri Lanka
Enter Sri Lanka, an import-dependent South Asian healthcare market NexorTest delivers end-to-end NMRA registration: Listed to Class III and IVD Class A to D, the 2025 reliance pathway, the new 2026 low-risk route, Foreign Manufacturing Site Approval, independent Local Agent (MAH) services, Import Licence and vigilance, all under one expert roof.
Risk-Based Device Classification Under Sri Lanka’s NMRA Act
Sri Lanka applies EU derived classification rules to general medical devices and a separate A to D scale to IVDs. Your class decides the pathway, site approval burden, MDEC depth and timeline.
Listed & Class I Devices
Toothbrushes, feeding bottles, bandages, cotton wool, walking aids and reusable surgical instruments. IVD Class A (culture media, buffers, stains) sits at the same tier.
- GL-037 Route
- FMSA Waived
- Cert + Import Licence
Class IIa Devices
Short-term invasive and many active diagnostic devices, including microneedling devices under the 2026 aesthetic classification. IVD Class B is the comparable tier.
- Reliance Eligible
- FMSA Required
- 5-Year Full Reg.
Class IIb Devices
Long-term invasive and higher-energy active devices, such as laser, RF, HIFU and cavitation aesthetic systems. IVD Class C is the comparable tier.
- Site Master File
- Reliance Eligible
- MDEC Review
Class III & IVD Class D
Implants, dermal fillers, active implantables and life-sustaining devices. Class D IVDs include blood-screening and high public-health-risk assays.
- Site Master File
- Clinical Evidence
- Full MDEC
Three Routes to Your NMRA Registration
Picking the right route, based on class and the approvals you already hold, is the single biggest lever on your Sri Lanka timeline.
Reliance Pathway
Reference-Country Reliance
For new applications already approved in the USA, UK, EU, Australia, Canada, Japan, Switzerland or Norway (plus Singapore for IVDs). NMRA relies on the reference assessment instead of repeating it.
- No sample importation
- No local performance evaluation
- Class III may still go to MDEC
Low-Risk Route
GL-037 Low-Risk Pathway
For Listed devices and non-active, non-sterile, non-measuring Class I devices and Class A IVDs. Completeness is checked before payment and NMRA issues the certificate and Import Licence together on approval.
- No foreign site registration
- No end-user performance evaluation
- 2-month window for deficiencies
Standard Route
Full Evaluation
For devices without an eligible reference approval. Sample import licence, sample evaluation and full MDEC review lead to a provisional registration (1 to 2 years), then full registration (5 years).
- Provisional: ~6 to 12 months
- Full: 6+ months from complete file
- FMSA must be in place
Comprehensive Sri Lanka Regulatory Services
From Local Agent appointment and site approval through MDEC review, Import Licence and vigilance, NexorTest manages every aspect of your NMRA regulatory journey.
Independent Local Agent / MAH
We act as your Sri Lanka Marketing Authorization Holder, holding registrations neutrally so you can appoint, add or change distributors without an NMRA transfer battle. We also manage MAH transfers away from existing distributors.
Foreign Manufacturing Site Approval
FMSA applications built to the NMRA accepting checklist: Letter of Authorization, Local Agent registration documents, ISO 13485 and a Site Master File for Class IIb, III and Class D IVD sites.
Classification & Categorisation
Rule-by-rule classification (Listed to Class III, IVD A to D), borderline product categorisation and product clarification letters, so you never build a dossier for the wrong pathway.
Reliance Pathway Submissions
We convert your FDA, CE, UKCA, TGA, Health Canada, PMDA, Swiss or Norwegian approval (or HSA for IVDs) into a reliance dossier with the certificate and decision letter NMRA expects.
GL-037 Low-Risk Pathway
Eligibility confirmation and fast, complete dossiers for Listed, Class I and Class A IVD products, built to clear the pre-payment completeness check first time.
Sample Licence & MDEC Management
For the standard route we secure the sample import licence, coordinate sample evaluation and manage MDEC queries so your file is decided at the next committee cycle.
Technical Dossier (STED)
Summary Technical Documentation, Declaration of Conformity, ISO 14971 risk files, verification and validation, clinical or performance evidence and sterilization or software validation.
Import Licence & Customs Readiness
Commercial Import Licence applications and annual renewals, plus coordination of Sri Lanka Atomic Energy Regulatory Council licensing for radiation-emitting devices.
Trilingual Labeling & Advertising
Label and IFU review with Sinhala, Tamil and English translation where required, registration-number placement, and NMRA approval of advertising and promotional material.
IVD & SaMD Registration
IVD Class A to D strategy with analytical and clinical performance evidence, and SaMD/AI dossiers covering IEC 62304 lifecycle, validation, cybersecurity and algorithm evidence.
Aesthetic Device Programme
Fixed-scope registration for fillers, implants, laser/RF/HIFU, fat-removal and microneedling devices ahead of the 23 July 2027 deadline, including distributor status checks.
Vigilance, Variations & Renewals
F-MDR-037 manufacturer reporting with a 24-hour escalation line, post-approval change notifications, provisional-to-full conversion and renewals filed 6 months before expiry.
Sri Lanka’s Trusted NMRA Specialist
We combine an on-the-ground Colombo regulatory team with global reference-market expertise to deliver faster, more predictable NMRA approvals.
Colombo-Based Regulatory Team
Specialists who work at the NMRA dossier accepting point and with MDEC cycles every month, not an offshore desk reading guidelines from a distance.
Independent MAH You Keep Control
Most competitors register in a distributor’s name. We hold your licence neutrally, so changing partners never means re-labeling or an NMRA transfer fight.
Current to November 2026
Our playbooks already include GL-037, the aesthetic-device rule, product clarification letters and the October 2026 vigilance forms, changes many guides still miss.
One Partner for South Asia
Coordinate Sri Lanka with India CDSCO, Bangladesh, the Maldives, Singapore HSA and your FDA/CE programme from a single integrated plan.
Transparent Fixed Fee Packages
Clear milestone pricing from classification to Import Licence. No hourly surprises, with government fees passed through at cost.
Six Steps to Your NMRA Registration
A structured, reliance-first approach that minimises MDEC queries and gets your device into Sri Lankan hospitals faster.
Classification & Pathway Strategy
We confirm your NMRA class and choose the low-risk, reliance or standard route based on risk and the reference approvals you already hold.
Appoint Independent MAH
NexorTest is appointed as your Local Agent under a Letter of Authorization, keeping your registrations independent of any distributor.
Foreign Manufacturing Site Approval
We file the FMSA, with a Site Master File for Class IIb, III and Class D IVD sites. Eligible low-risk devices skip this step.
Dossier & Labeling
We compile the STED, ISO 13485, Free Sale Certificate, reference approvals, risk and clinical evidence, and compliant labels and IFU.
Submission, Samples & MDEC
We submit at the NMRA accepting point, handle the sample import licence and testing where needed, and answer MDEC queries.
Registration, Import Licence & Post-Market
You receive provisional then 5-year full registration; we obtain the Import Licence and run vigilance, variations and renewals.
NMRA Expertise Across Every Device Category
From low-risk consumables to implants, IVDs and AI software, our specialists cover the full breadth of medical technology entering Sri Lanka.
- 🫀 Cardiovascular & Implants
- 🧬 In Vitro Diagnostics
- ✨ Aesthetic & Dermal Fillers
- 🤖 AI & SaMD
- 🩻 Imaging & Radiology
- 🦴 Orthopaedics
- 💉 Infusion & Drug Delivery
- 🩸 Surgical Instruments
- 👁 Ophthalmics
- 🦷 Dental Devices
- 🩹 Wound Care & Consumables
- 🏥 Hospital Equipment
- 📱 Wearables & Monitoring
NMRA Registration Sri Lanka FAQ’s
What is NMRA medical device registration in Sri Lanka?
NMRA medical device registration is the mandatory market authorization issued by the National Medicines Regulatory Authority, the independent regulator under Sri Lanka’s Ministry of Health established by the NMRA Act No. 5 of 2015. No medical device or IVD may be imported, manufactured, stored for sale or sold in Sri Lanka without registration unless a specific exemption applies. Market entry is a two-step process: first a Registration Certificate, then a separate Import Licence for commercial consignments. Foreign manufacturers apply through a Sri Lanka-based Local Agent, also called the Marketing Authorization Holder (MAH), and most must first obtain Foreign Manufacturing Site Approval (FMSA). Technical evaluation is carried out by the Medical Devices Evaluation Committee (MDEC). First-time products typically receive a provisional registration valid for 1 or 2 years, followed by a full registration valid for 5 years.
How are medical devices classified in Sri Lanka?
Sri Lanka uses an EU-derived, rule-based classification. General medical devices are grouped as Listed devices (lowest risk, such as toothbrushes and feeding bottles), Class I (such as reusable surgical instruments and cotton wool), Class IIa, Class IIb and Class III (highest risk, such as implants and dermal fillers). IVDs follow a separate four-tier scale from Class A (lowest) to Class D (highest individual and public health risk). Classification decides whether the low-risk pathway, the reliance pathway or the standard full evaluation applies, whether site approval and a Site Master File are needed, and how deep the MDEC review will be. The NMRA also offers product categorisation for borderline products.
What is the NMRA reliance pathway for medical devices?
Introduced by the NMRA in 2025, the reliance pathway lets new medical device applications draw on approvals already granted by recognised reference regulators. For general medical devices the reference jurisdictions are the USA, UK, Australia, Canada, Japan, Norway, Switzerland and all EU member states; for IVDs, Singapore is added. Eligible devices can avoid sample importation and local performance evaluation, which removes the slowest steps of the standard route. The pathway applies to new applications, not renewals or variations, and Class III devices may still be referred to the MDEC for full review. NexorTest builds reliance dossiers from your FDA, CE, UKCA, TGA, Health Canada or PMDA approval, and HSA approval for IVDs.
What is the NMRA low-risk device pathway introduced in May 2026?
On 13 May 2026 the NMRA published a dedicated guideline for listed devices, Class I general medical devices and Class A IVDs. To qualify, Class I devices and Class A IVDs must be non-active, non-sterile and have no measuring function; examples include bandages, hospital beds, walking aids, manual breast pumps, culture media and buffer solutions. Eligible products are exempt from foreign manufacturing site registration, GMP inspection for local manufacturers and end-user performance evaluation. Dossiers are checked for completeness before payment, deficiencies must be answered within two months, and on approval the NMRA issues both the registration certificate and the import licence.
How long is an NMRA medical device registration valid?
First-time registrations are usually issued as a provisional registration valid for 1 or 2 years, as stated on the certificate. After satisfactory evaluation, full registration is granted for 5 years. The Import Licence is issued separately and is typically valid for 1 year. Renewal applications should be lodged 6 months before expiry, and a lapsed registration generally means starting again as a new application. Changes to a registered device, such as new variants, accessories or indications, must be notified to the NMRA with supporting documents.
Do aesthetic devices need NMRA registration in Sri Lanka?
Yes. On 23 July 2026 the NMRA formally classified five aesthetic-related categories as medical devices: implants for body modification and injectable dermal or mucosal fillers (Class III), laser, RF, HIFU and cavitation skin devices (Class IIb), invasive fat-removal devices (Class IIa or IIb) and microneedling devices (Class IIa). A one-year grace period applies, so affected products must be registered by 23 July 2027. Given dossier and MDEC timelines, Class III manufacturers in particular should start now.
What are the NMRA adverse event reporting requirements for medical devices?
In October 2026 the NMRA published dedicated adverse event forms: F-MDR-036 for importers and suppliers, F-MDR-037 for manufacturers and F-MDR-038 for consumers and healthcare facilities. Events involving death or serious deterioration in health must be reported within 24 hours, events where these might have occurred within 14 days, and all other adverse events within 30 days. Reportable events include malfunctions, design or manufacturing deficiencies, labeling and IFU errors, and false IVD results. NexorTest runs vigilance as your MAH with a 24-hour escalation process across time zones.
What are the labeling requirements for medical devices in Sri Lanka?
Labels must carry the approved device name, manufacturer and Local Agent details and traceability information such as lot or batch and dates, and the Sri Lanka registration number is added after approval. English is widely accepted for professional-use devices, but Sinhala and/or Tamil may be required, particularly for devices intended for patient self-use, in line with Sri Lanka’s official language policy. Advertising and promotional material for medical devices requires NMRA approval before use.
Ready to Enter the Sri Lankan Medical Device Market?
Get a free NMRA regulatory assessment. We’ll confirm your class, check reliance and low-risk eligibility, and map your fastest path to a Registration Certificate and Import Licence.